A Study to Assess How Food Affects the Safety and Pharmacokinetics of Galicaftor and Navocaftor

על הניסוי

Cystic Fibrosis (CF) is a rare, life-threatening, genetic disease that affects the lungs and digestive system, significantly impairing the quality of life, with those affected having a median age of death at 40. The objectives of this study are to assess the effect of food on the safety and pharmacokinetics of navocaftor and galicaftor.

צפו ב-NCT05538585 ב-ClinicalTrials.gov ←

קישורים קשורים

ניסויים קשורים